apratoxin S4 (Oceanyx Pharmaceuticals)

N/A

Report date: 2025/01/26 17:34:15
NME

Base Information

Drug Nameapratoxin S4 (Oceanyx Pharmaceuticals)
Drug Alias Nameapratoxin S4apratoxin S8apratoxin S8 (Oceanyx Pharmaceuticals)
ClassificationSmall molecules > Peptidomimetic
Mechanisms of ActionVascular endothelial growth factor modulators
TargetsVascular endothelial growth factor
Therapy Area/IndicationsAngiogenesis disorderColorectal Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesUniversity Of Florida
China Registration ClassN/A

Develop Information

Active CompaniesOceanyx Pharmaceuticals IncUniversity Of Florida
Inactive CompaniesN/A
Active IndicationsAngiogenesis disorderColorectal Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A